SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (1311)10/12/1997 11:27:00 AM
From: Richard Cohen   of 1762
 
Gentlemen- I am new to this board but I am fascinated by the impact of the new drug. I was speaking to my cousin yesterday who is an oncologist in the Philadelphia area who feels this drug will hugely impact the lymphoma treatment market. How long has this new treatment been available to the public? Has it been factored into the current stock price? Finally, with the recent surge in stock price,is it too late to purchas the stock for a long term hold? Any input would be appreciated. Thanks, Rich
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext